[Effect of a poly I-poly C complex with poly-L-lysine on experimental tick-borne encephalitis]. 1977

M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin

The influence of the poly(I)-poly(C) complex with poly-l-lysine on the development and course of experimental tick-borne encephalitis was studied in Macaca rhesus monkeys. Prophylactic administration of the substance under study, although not preventing the disease, modified its course and facilitated recovery of the animals. Poly(I)-poly(C) and its complex with poly-l-lysine were shown to have no effect on production of infectious virus or its antigen demonstrable by the immunofluorescence procedure in HEp-2 cells chronically infected with tick-borne encephalitis virus.

UI MeSH Term Description Entries
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008251 Macaca A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes. Ape, Barbary,Ape, Black,Ape, Celebes,Barbary Ape,Black Ape,Celebes Ape,Macaque,Apes, Barbary,Apes, Black,Apes, Celebes,Barbary Apes,Black Apes,Celebes Apes,Macacas,Macaques
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011070 Poly I-C Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid. Poly(I-C),Poly(rI).Poly(rC),Polyinosinic-Polycytidylic Acid,Polyinosinic-Polycytidylic Acid (High MW),Polyriboinosinic-Polyribocytidylic Acid,Polyribose Inosin-Cytidil,Inosin-Cytidil, Polyribose,Poly I C,Polyinosinic Polycytidylic Acid,Polyriboinosinic Polyribocytidylic Acid,Polyribose Inosin Cytidil
D011107 Polylysine A peptide which is a homopolymer of lysine. Epsilon-Polylysine,Poly-(Alpha-L-Lysine),Epsilon Polylysine
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug

Related Publications

M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
May 1977, Antibiotiki,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
May 1964, Antibiotiki,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
January 1991, Voprosy virusologii,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
October 1954, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
January 1962, Journal of hygiene, epidemiology, microbiology, and immunology,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
January 1954, Przeglad epidemiologiczny,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
November 1982, Antibiotiki,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
January 2011, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
January 1954, Przeglad epidemiologiczny,
M P Burgasova, and O G Andzhaparidze, and T A Bektemirov, and N N Bogomolova, and Iu S Boriskin
June 1980, Acta virologica,
Copied contents to your clipboard!